All News

Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.

In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.

Tarah Davis, PharmD, MBA, AFMC, discusses the superpower of personalized patient roadmaps and how identifying drug-induced nutrient depletions is the key to resolving digestive dysfunction.

Pharmacists guide safe OTC allergy choices and compare Allegra, Claritin, and Zyrtec for fast, 24-hour relief from sneezing and itchy eyes.

The FDA approved Foundayo, which is an oral glucagon-like peptide-1 receptor agonist, for weight loss.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

Patient-centered tools like the Patient's Global Impression of Change scale better assess symptoms, function, quality of life, and treatment effectiveness.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

Community pharmacists help prevent chronic wounds with early triage, modern dressing guidance, and diabetic foot care.

Mississippi pharmacy thrives by pioneering medication synchronization, medication packs, and clinical services, cutting chaos and boosting patient care.

As PBM-pharmacy relationships evolve in real time, staying proactive when a PBM audit comes through could be the difference between thriving and losing essential business.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.

Through transformational, authentic, servant, and distributed models, researchers explore the impact of leadership on the pharmacy workforce.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.

Nonopioid pain relief medications include acetaminophen, nonsteroidal anti-inflammatory drugs, suzetrigine, and adjuvant pain management drugs.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Alyssa Perry, PharmD to discuss the pharmacist’s role in ensuring inclusive and respectful care for members of the LGBTQ+ community.

GSK and Spero Therapeutics’ newly approved carbapenem could be a standard of care in adults with complicated urinary tract infections who prefer oral administration.

In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.

Pharmacists help patients stay safe with hydration, medication review, warning signs, and cooling resources.

Expanding pharmacy-based screening through a root-cause lens allows pharmacists to identify early dysfunction and improve outcomes.

Community pharmacies redesign workflows to address insurance barriers and deliver safer, gender-affirming care.

As health care spending and polypharmacy increase, researchers are exploring new ways to deprescribe medications, looking to pharmacists to fill in a gap.

Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.

A study examining naloxone sales found that retail OTC sales have been surprisingly limited despite improvements in access.